922 related articles for article (PubMed ID: 23810085)
1. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
[TBL] [Abstract][Full Text] [Related]
2. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.
Verdejo C; Hervías D; Roncero Ó; Arias Á; Bouhmidi A; Lorente R; Salueña I; Lucendo AJ
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1521-1527. PubMed ID: 30303822
[TBL] [Abstract][Full Text] [Related]
4. A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis.
Lobatón T; Rodríguez-Moranta F; Lopez A; Sánchez E; Rodríguez-Alonso L; Guardiola J
Inflamm Bowel Dis; 2013 Apr; 19(5):1034-42. PubMed ID: 23470502
[TBL] [Abstract][Full Text] [Related]
5. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
7. Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohn's Disease.
Garcia-Planella E; Mañosa M; Cabré E; Marín L; Gordillo J; Zabana Y; Boix J; Sáinz S; Domènech E
Inflamm Bowel Dis; 2016 Dec; 22(12):2879-2885. PubMed ID: 27824646
[TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients.
Lin WC; Wong JM; Tung CC; Lin CP; Chou JW; Wang HY; Shieh MJ; Chang CH; Liu HH; Wei SC;
World J Gastroenterol; 2015 Dec; 21(48):13566-73. PubMed ID: 26730169
[TBL] [Abstract][Full Text] [Related]
10. Serum calprotectin as a biomarker for Crohn's disease.
Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
[TBL] [Abstract][Full Text] [Related]
11. Impact of disease location on fecal calprotectin levels in Crohn's disease.
Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
[TBL] [Abstract][Full Text] [Related]
12. Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic strictures.
Lopes S; Andrade P; Rodrigues-Pinto E; Afonso J; Macedo G; Magro F
World J Gastroenterol; 2017 Sep; 23(35):6482-6490. PubMed ID: 29085198
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
Lasson A; Strid H; Ohman L; Isaksson S; Olsson M; Rydström B; Ung KA; Stotzer PO
J Crohns Colitis; 2014 Aug; 8(8):789-95. PubMed ID: 24418661
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Fecal Inflammatory Markers in Crohn's Disease.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB
Inflamm Bowel Dis; 2016 May; 22(5):1086-94. PubMed ID: 26818420
[TBL] [Abstract][Full Text] [Related]
15. Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study.
Reinisch W; Panaccione R; Bossuyt P; Baert F; Armuzzi A; Hébuterne X; Travis S; Danese S; Sandborn WJ; Schreiber S; Berg S; Zhou Q; Kligys K; Neimark E; Suleiman AA; D'Haens G; Colombel JF
Inflamm Bowel Dis; 2020 Sep; 26(10):1562-1571. PubMed ID: 32105310
[TBL] [Abstract][Full Text] [Related]
16. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
Boschetti G; Laidet M; Moussata D; Stefanescu C; Roblin X; Phelip G; Cotte E; Passot G; Francois Y; Drai J; Del Tedesco E; Bouhnik Y; Flourie B; Nancey S
Am J Gastroenterol; 2015 Jun; 110(6):865-72. PubMed ID: 25781366
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Calprotectin and Modified Rutgeerts Score.
Lopes S; Andrade P; Afonso J; Rodrigues-Pinto E; Dias CC; Macedo G; Magro F
Inflamm Bowel Dis; 2016 Sep; 22(9):2173-81. PubMed ID: 27482974
[TBL] [Abstract][Full Text] [Related]
19. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
20. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.
Schaffer T; Schoepfer AM; Seibold F;
J Crohns Colitis; 2014 Sep; 8(9):1125-32. PubMed ID: 24636141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
